8.7598
                                            Fulcrum Therapeutics Inc Aktie (FULC) Neueste Nachrichten
How Fulcrum Therapeutics Inc. stock responds to policy changesPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com
Identifying reversal signals in Fulcrum Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting - The Manila Times
Fulcrum Therapeutics to Present Phase 1b PIONEER Trial Data on Pociredir for Sickle Cell Disease at ASH 2025 - Quiver Quantitative
Will Fulcrum Therapeutics Inc. stock gain from strong economyJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Will Fulcrum Therapeutics Inc. stock beat EPS estimatesTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Can Fulcrum Therapeutics Inc. stock resist sector downturns2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Multi asset correlation models including Fulcrum Therapeutics Inc.July 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
How sustainable is Fulcrum Therapeutics Inc. stock dividend payoutMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chartQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com
Statistical indicators supporting Fulcrum Therapeutics Inc.’s strengthMarket Growth Review & Pattern Based Trade Signal System - newser.com
How to track smart money flows in Fulcrum Therapeutics Inc.Watch List & Free Risk Controlled Daily Trade Plans - newser.com
What is Leerink Partnrs' Estimate for FULC FY2025 Earnings? - MarketBeat
FY2025 EPS Forecast for Fulcrum Therapeutics Cut by Analyst - MarketBeat
FY2025 EPS Estimate for Fulcrum Therapeutics Cut by Analyst - MarketBeat
How to build a dashboard for Fulcrum Therapeutics Inc. stockBreakout Watch & Verified High Yield Trade Plans - newser.com
Why Fulcrum Therapeutics Inc. stock is in analyst buy zone2025 Short Interest & Fast Gaining Stock Reports - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Macro Impact & Short-Term High Return Strategies - newser.com
Will Fulcrum Therapeutics Inc. continue its uptrendPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-11-02 22:53:39 - newser.com
Why Fulcrum Therapeutics Inc. stock remains on buy listsWeekly Trade Recap & Fast Entry High Yield Tips - newser.com
Signal strength of Fulcrum Therapeutics Inc. stock in tech scannersJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Fulcrum Therapeutics Inc. stock volume spike explainedMarket Risk Summary & Capital Protection Trade Alerts - newser.com
What risks investors should watch in Fulcrum Therapeutics Inc. stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityMarket Movement Recap & Technical Entry and Exit Tips - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen - MarketBeat
What is HC Wainwright's Estimate for FULC Q1 Earnings? - MarketBeat
How institutional buying supports Fulcrum Therapeutics Inc. stockJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Price Target Raised to $7.00 - MarketBeat
Published on: 2025-10-31 05:47:11 - newser.com
Is Fulcrum Therapeutics Inc. trending in predictive chart modelsBreakout Watch & High Return Trade Guides - newser.com
How to forecast Fulcrum Therapeutics Inc. trends using time series - newser.com
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights: Promising Advances in Sickle ... By GuruFocus - Investing.com Canada
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights - GuruFocus
Fulcrum Therapeutics (FULC) Price Target Increased by 10.32% to 12.46 - MSN
RBC Capital Updates Fulcrum Therapeutics (FULC) Price Target Ami - GuruFocus
Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):